These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Primary ovarian insufficiency in a female with phosphomannomutase-2 gene (PMM2) mutations for congenital disorder of glycosylation. Masunaga Y; Mochizuki M; Kadoya M; Wada Y; Okamoto N; Fukami M; Kato F; Saitsu H; Ogata T Endocr J; 2021 May; 68(5):605-611. PubMed ID: 33583911 [TBL] [Abstract][Full Text] [Related]
7. Clinical, laboratory and molecular findings and long-term follow-up data in 96 French patients with PMM2-CDG (phosphomannomutase 2-congenital disorder of glycosylation) and review of the literature. Schiff M; Roda C; Monin ML; Arion A; Barth M; Bednarek N; Bidet M; Bloch C; Boddaert N; Borgel D; Brassier A; Brice A; Bruneel A; Buissonnière R; Chabrol B; Chevalier MC; Cormier-Daire V; De Barace C; De Maistre E; De Saint-Martin A; Dorison N; Drouin-Garraud V; Dupré T; Echenne B; Edery P; Feillet F; Fontan I; Francannet C; Labarthe F; Gitiaux C; Héron D; Hully M; Lamoureux S; Martin-Coignard D; Mignot C; Morin G; Pascreau T; Pincemaille O; Polak M; Roubertie A; Thauvin-Robinet C; Toutain A; Viot G; Vuillaumier-Barrot S; Seta N; De Lonlay P J Med Genet; 2017 Dec; 54(12):843-851. PubMed ID: 28954837 [TBL] [Abstract][Full Text] [Related]
8. A quantitative assessment of the evolution of cerebellar syndrome in children with phosphomannomutase-deficiency (PMM2-CDG). Serrano NL; De Diego V; Cuadras D; Martinez Monseny AF; Velázquez-Fragua R; López L; Felipe A; Gutiérrez-Solana LG; Macaya A; Pérez-Dueñas B; Serrano M; Orphanet J Rare Dis; 2017 Sep; 12(1):155. PubMed ID: 28915903 [TBL] [Abstract][Full Text] [Related]
9. Natural Killer Cell Receptors and Cytotoxic Activity in Phosphomannomutase 2 Deficiency (PMM2-CDG). García-López R; de la Morena-Barrio ME; Alsina L; Pérez-Dueñas B; Jaeken J; Serrano M; Casado M; Hernández-Caselles T PLoS One; 2016; 11(7):e0158863. PubMed ID: 27415628 [TBL] [Abstract][Full Text] [Related]
10. Longitudinal volumetric and 2D assessment of cerebellar atrophy in a large cohort of children with phosphomannomutase deficiency (PMM2-CDG). de Diego V; Martínez-Monseny AF; Muchart J; Cuadras D; Montero R; Artuch R; Pérez-Cerdá C; Pérez B; Pérez-Dueñas B; Poretti A; Serrano M; J Inherit Metab Dis; 2017 Sep; 40(5):709-713. PubMed ID: 28341975 [TBL] [Abstract][Full Text] [Related]
11. Initial diagnosis of the congenital disorder of glycosylation PMM2-CDG (CDG1a) in a 4-year-old girl after neurosurgical intervention for cerebral hemorrhage. Stefanits H; Konstantopoulou V; Kuess M; Milenkovic I; Matula C J Neurosurg Pediatr; 2014 Nov; 14(5):546-9. PubMed ID: 25192236 [TBL] [Abstract][Full Text] [Related]
12. Stroke-Like Episodes in PMM2-CDG: When the Lack of Other Evidence Is the Only Evidence. Serrano M Front Pediatr; 2021; 9():717864. PubMed ID: 34708008 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of Cell Models to Study Monocyte Functions in PMM2 Congenital Disorders of Glycosylation. de Haas P; de Jonge MI; Koenen HJPM; Joosten B; Janssen MCH; de Boer L; Hendriks WJAJ; Lefeber DJ; Cambi A Front Immunol; 2022; 13():869031. PubMed ID: 35603178 [TBL] [Abstract][Full Text] [Related]
14. Liposome-encapsulated mannose-1-phosphate therapy improves global N-glycosylation in different congenital disorders of glycosylation. Budhraja R; Radenkovic S; Jain A; Muffels IJJ; Ismaili MHA; Kozicz T; Pandey A; Morava E Mol Genet Metab; 2024 Jun; 142(2):108487. PubMed ID: 38733638 [TBL] [Abstract][Full Text] [Related]
15. A mouse model of a human congenital disorder of glycosylation caused by loss of PMM2. Chan B; Clasquin M; Smolen GA; Histen G; Powe J; Chen Y; Lin Z; Lu C; Liu Y; Cang Y; Yan Z; Xia Y; Thompson R; Singleton C; Dorsch M; Silverman L; Su SM; Freeze HH; Jin S Hum Mol Genet; 2016 Jun; 25(11):2182-2193. PubMed ID: 27053713 [TBL] [Abstract][Full Text] [Related]
16. Sorbitol Is a Severity Biomarker for PMM2-CDG with Therapeutic Implications. Ligezka AN; Radenkovic S; Saraswat M; Garapati K; Ranatunga W; Krzysciak W; Yanaihara H; Preston G; Brucker W; McGovern RM; Reid JM; Cassiman D; Muthusamy K; Johnsen C; Mercimek-Andrews S; Larson A; Lam C; Edmondson AC; Ghesquière B; Witters P; Raymond K; Oglesbee D; Pandey A; Perlstein EO; Kozicz T; Morava E Ann Neurol; 2021 Dec; 90(6):887-900. PubMed ID: 34652821 [TBL] [Abstract][Full Text] [Related]
17. Genotypes and estimated prevalence of phosphomannomutase 2 deficiency in Turkey differ significantly from those in Europe. Yıldız Y; Arslan M; Çelik G; Kasapkara ÇS; Ceylaner S; Dursun A; Sivri HS; Coşkun T; Tokatlı A Am J Med Genet A; 2020 Apr; 182(4):705-712. PubMed ID: 31981409 [TBL] [Abstract][Full Text] [Related]
18. Synaptic roles for phosphomannomutase type 2 in a new Drosophila congenital disorder of glycosylation disease model. Parkinson WM; Dookwah M; Dear ML; Gatto CL; Aoki K; Tiemeyer M; Broadie K Dis Model Mech; 2016 May; 9(5):513-27. PubMed ID: 26940433 [TBL] [Abstract][Full Text] [Related]